Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FDA grants final marketing approval for Corlopam

Sep. 25, 1997

Irbesartan introduced in first markets

Sep. 25, 1997

VasoCare reduces stress in animal model of hypertension

Sep. 24, 1997

Novel iron complex available for licensing from MoliChem Medicines

Sep. 24, 1997

Merck KGaA claims new Na+/H+-exchange inhibitors

Sep. 24, 1997

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Dual IL-6/NO production inhibitors prepared at Takeda

Sep. 19, 1997

Dual ACE/NEP inhibitors described by Zambon

Sep. 18, 1997

KRN-4884 active in several preclinical models of hypertension

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...